Summary
When the Biden administration removed the safeguard of in-person dispensing for the abortion drug mifepristone, it intentionally opened the door for out-of-state pro-abortion activists and doctors to mail streams of high-risk abortion drugs into pro-life states. Louisiana, which has chosen to protect the lives of unborn babies, and Rosalie Markezich, a Louisiana woman coerced into taking abortion drugs that her boyfriend obtained via mail from a doctor in California, are suing the U.S. Food and Drug Administration for unlawfully approving this reckless mail-order abortion-drug scheme.
Case Timeline
- June 2022: The Supreme Court overturns Roe v. Wade in Dobbs v. Jackson Women’s Health Organization. Louisiana’s pro-life laws immediately go into effect following that decision.
- January 2023: The Biden FDA permanently removes the in-person dispensing requirement from the Mifepristone Risk Evaluation and Mitigation Strategy, making abortion drugs available by mail.
- October 2023: Rosalie Markezich feels coerced into taking abortion drugs in pro-life Louisiana after her then-boyfriend ordered abortion drugs from a provider in California.
- October 2025: Alongside ADF attorneys, the State of Louisiana and Rosalie sue the FDA in the U.S. District Court for the Western District of Louisiana, Lafayette Division for its 2023 actions.
Case Profile
Erin Morrow Hawley
Of Counsel
View Profile